KESTRA MEDICAL TECHNOLOGIES, LTD.KMTSEarnings & Financial Report
Nasdaq
NextMar 11, 2026
KMTS Q2 2026 Key Financial Metrics
Revenue
$22.6M
Gross Profit
$11.4M
Operating Profit
$-31.8M
Net Profit
$-32.8M
Gross Margin
50.6%
Operating Margin
-140.7%
Net Margin
-145.3%
YoY Growth
N/A
EPS
$-0.64
Financial Flow
KESTRA MEDICAL TECHNOLOGIES, LTD. Q2 2026 Financial Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. reported revenue of $22.6M for Q2 2026, with a net profit of $-32.8M (-145.3% margin). Cost of goods sold was $11.1M, operating expenses totaled $43.2M.
Key Financial Metrics
| Total Revenue | $22.6M |
|---|---|
| Net Profit | $-32.8M |
| Gross Margin | 50.6% |
| Operating Margin | -140.7% |
| Report Period | Q2 2026 |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|
| Revenue | $12.8M | $14.7M | $19.4M | $22.6M |
| YoY Growth | N/A | N/A | N/A | N/A |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|
| Assets | N/A | N/A | $266.3M | $246.7M |
| Liabilities | N/A | N/A | $82.1M | $82.6M |
| Equity | $-216.5M | $-236.5M | $184.2M | $164.1M |
Cash Flow
| Q3 2024 | Q1 2026 | Q2 2026 | |
|---|---|---|---|
| Operating CF | $-17.5M | $-26.3M | $-18.3M |